Home › Chronic Myelomonocytic Leukemia › California › Los Angeles
Chronic Myelomonocytic Leukemia clinical trials in Los Angeles, CA
3 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- UCLA Medical Center, Los Angeles
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- Keck School of Medicine of USC, Los Angeles
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
RecruitingPhase 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX16 studies
- Seattle, WA10 studies
- Boston, MA7 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- Rochester, MN6 studies
- New York City, NY6 studies
- Durham, NC5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Columbus, OH4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.